Researcher at Johns Hopkins University receives International AIDS Society TB/HIV prize

12 July 2012 - Geneva - Jonathan Golub, an associate professor at Johns Hopkins School of Medicine and Bloomberg School of Public Health at, is the winner of this year’s International AIDS Society TB/HIV Prize.

The aim of the US$ 2000 prize on TB/HIV research is to generate interest and stimulate research on basic, clinical and operations research in TB/HIV prevention, care and treatment. The IAS TB/HIV Research Prize is an incentive for researchers to investigate pertinent research questions that affect TB/HIV co-infection and operational effectiveness of core TB/HIV collaborative services.

Dr Golub’s primary research focus is the epidemiology of TB, primarily in the context of HIV infection. He leads a large community randomized trial in Brazil investigating isoniazid preventive therapy for HIV-infected patients as part of the CREATE consortium. He also conducts research in South Africa, working on several HIV-related studies at the Chris Hani Baragwanath Hospital in Soweto. He also has a strong interest in the link between smoking , diabetes and TB and HIV and is involved in several studies on these issues.

Since 2005, he has been the primary instructor for the Epidemiologic Basis for Tuberculosis Control, a class developed by Dr George W. Comstock. This course is conducted twice-yearly, both in class and online as part of the distance education program at Johns Hopkins University. He also has developed a one-year training course for Brazilian and South African clinicians and epidemiologists emphasizing methods in developing, implementing and analyzing epidemiologic studies. This course concentrates on HIV/TB population research, and has now expanded through another training grant to include trainees from these countries interested in HIV-related malignancies.

Dr Golub’s prize will be conferred on July 27 during AIDS 2012, the International AIDS Conference in Washington, DC.